10-Q 1 ghc-20240331.htm FORM 10-Q ghc-20240331
false2024Q1000010488912/3100001048892024-01-012024-03-310000104889us-gaap:CommonClassAMember2024-04-26xbrli:shares0000104889us-gaap:CommonClassBMember2024-04-260000104889us-gaap:ServiceMember2024-01-012024-03-31iso4217:USD0000104889us-gaap:ServiceMember2023-01-012023-03-310000104889us-gaap:ProductMember2024-01-012024-03-310000104889us-gaap:ProductMember2023-01-012023-03-3100001048892023-01-012023-03-31iso4217:USDxbrli:shares00001048892024-03-3100001048892023-12-3100001048892022-12-3100001048892023-03-310000104889us-gaap:CommonStockMember2023-12-310000104889us-gaap:AdditionalPaidInCapitalMember2023-12-310000104889us-gaap:RetainedEarningsMember2023-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000104889us-gaap:TreasuryStockCommonMember2023-12-310000104889us-gaap:NoncontrollingInterestMember2023-12-310000104889us-gaap:RetainedEarningsMember2024-01-012024-03-310000104889us-gaap:NoncontrollingInterestMember2024-01-012024-03-310000104889us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000104889us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000104889us-gaap:CommonStockMember2024-03-310000104889us-gaap:AdditionalPaidInCapitalMember2024-03-310000104889us-gaap:RetainedEarningsMember2024-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000104889us-gaap:TreasuryStockCommonMember2024-03-310000104889us-gaap:NoncontrollingInterestMember2024-03-310000104889us-gaap:CommonStockMember2022-12-310000104889us-gaap:AdditionalPaidInCapitalMember2022-12-310000104889us-gaap:RetainedEarningsMember2022-12-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000104889us-gaap:TreasuryStockCommonMember2022-12-310000104889us-gaap:NoncontrollingInterestMember2022-12-310000104889us-gaap:RetainedEarningsMember2023-01-012023-03-310000104889us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000104889us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000104889us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000104889us-gaap:CommonStockMember2023-03-310000104889us-gaap:AdditionalPaidInCapitalMember2023-03-310000104889us-gaap:RetainedEarningsMember2023-03-310000104889us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000104889us-gaap:TreasuryStockCommonMember2023-03-310000104889us-gaap:NoncontrollingInterestMember2023-03-310000104889ghc:TelevisionBroadcastingMember2024-03-31ghc:televisionStation0000104889ghc:AutomotiveMember2024-03-31ghc:automotiveDealership0000104889srt:ScenarioPreviouslyReportedMember2023-01-012023-03-310000104889srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2023-01-012023-03-310000104889us-gaap:AllOtherSegmentsMember2024-01-012024-01-31ghc:business00001048892023-01-012023-12-310000104889ghc:GrahamHealthcareGroupMember2023-01-012023-12-310000104889ghc:AutomotiveMember2023-01-012023-12-310000104889us-gaap:AllOtherSegmentsMember2023-01-012023-12-310000104889ghc:GrahamHealthcareGroupMember2023-01-012023-01-310000104889us-gaap:AllOtherSegmentsMember2023-07-012023-07-310000104889ghc:AutodealershipsMemberghc:AutomotiveMember2023-09-300000104889ghc:GrahamHealthcareGroupMember2023-12-012023-12-310000104889us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMember2023-12-012023-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:CashPaidForCSIMinoritySharesMember2023-12-012023-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNoteForCSIMinoritySharesMember2023-12-012023-12-310000104889ghc:CSIPharmacyHoldingCompanyLLCMemberghc:PromissoryNoteForCSIMinoritySharesMember2023-12-31xbrli:pure0000104889ghc:GrahamHoldingsCompanyMemberghc:CSIPharmacyHoldingCompanyLLCMember2024-03-310000104889ghc:MarkelGroupIncMember2023-12-310000104889ghc:MarkelGroupIncMember2024-03-310000104889ghc:BerkshireHathawayMemberus-gaap:CommonClassAMember2024-03-310000104889ghc:BerkshireHathawayMemberus-gaap:CommonClassBMember2024-03-310000104889ghc:BerkshireHathawayMember2024-03-310000104889ghc:ConcentrationInSingleMarketableEquitySecurityMemberus-gaap:AssetsTotalMember2024-01-012024-03-310000104889ghc:N2KNetworksMember2024-03-310000104889ghc:RealmMember2024-03-310000104889ghc:IntersectionMember2024-03-310000104889ghc:IntersectionMember2024-01-012024-03-310000104889ghc:GrahamHealthcareGroupMemberghc:ResidentialAndMichiganHospitalJointVentureMember2024-03-310000104889ghc:GrahamHealthcareGroupMemberghc:ResidentialHomeHealthIllinoisMember2024-03-310000104889ghc:CelticHealthcareAlleghenyHealthNetworkJointVentureMemberghc:GrahamHealthcareGroupMember2024-03-310000104889ghc:GrahamHealthcareGroupMemberghc:ResidentialHospiceIllinoisMember2024-03-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:RelatedPartyMember2024-01-012024-03-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:RelatedPartyMember2023-01-012023-03-310000104889ghc:YorkJointVentureMemberghc:KIHLMember2024-03-31iso4217:GBP0000104889ghc:YorkJointVentureMemberghc:KIHLMember2024-01-012024-03-310000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityMember2024-01-012024-03-310000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityMember2023-01-012023-03-310000104889ghc:AutomotiveMember2024-01-012024-03-310000104889ghc:AutomotiveMember2023-01-012023-03-310000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityNewVehiclesMember2024-03-310000104889ghc:AutomotiveMemberghc:VehicleFloorPlanFacilityNewVehiclesMember2023-12-310000104889ghc:EducationMember2023-12-310000104889ghc:TelevisionBroadcastingMember2023-12-310000104889ghc:ManufacturingMember2023-12-310000104889ghc:GrahamHealthcareGroupMember2023-12-310000104889ghc:AutomotiveMember2023-12-310000104889us-gaap:AllOtherSegmentsMember2023-12-310000104889ghc:EducationMember2024-01-012024-03-310000104889ghc:TelevisionBroadcastingMember2024-01-012024-03-310000104889ghc:ManufacturingMember2024-01-012024-03-310000104889ghc:GrahamHealthcareGroupMember2024-01-012024-03-310000104889us-gaap:AllOtherSegmentsMember2024-01-012024-03-310000104889ghc:EducationMember2024-03-310000104889ghc:ManufacturingMember2024-03-310000104889ghc:GrahamHealthcareGroupMember2024-03-310000104889us-gaap:AllOtherSegmentsMember2024-03-310000104889ghc:KaplanInternationalMemberghc:EducationMember2023-12-310000104889ghc:HigherEducationMemberghc:EducationMember2023-12-310000104889ghc:SupplementalEducationMemberghc:EducationMember2023-12-310000104889ghc:KaplanInternationalMemberghc:EducationMember2024-01-012024-03-310000104889ghc:HigherEducationMemberghc:EducationMember2024-01-012024-03-310000104889ghc:SupplementalEducationMemberghc:EducationMember2024-01-012024-03-310000104889ghc:KaplanInternationalMemberghc:EducationMember2024-03-310000104889ghc:HigherEducationMemberghc:EducationMember2024-03-310000104889ghc:SupplementalEducationMemberghc:EducationMember2024-03-310000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2024-03-310000104889srt:MinimumMemberus-gaap:CustomerRelationshipsMember2023-12-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2024-03-310000104889srt:MaximumMemberus-gaap:CustomerRelationshipsMember2023-12-310000104889us-gaap:CustomerRelationshipsMember2024-03-310000104889us-gaap:CustomerRelationshipsMember2023-12-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2024-03-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MinimumMember2023-12-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2024-03-310000104889us-gaap:TrademarksAndTradeNamesMembersrt:MaximumMember2023-12-310000104889us-gaap:TrademarksAndTradeNamesMember2024-03-310000104889us-gaap:TrademarksAndTradeNamesMember2023-12-310000104889us-gaap:ContractBasedIntangibleAssetsMember2024-03-310000104889us-gaap:ContractBasedIntangibleAssetsMember2023-12-310000104889srt:MinimumMemberus-gaap:DatabasesMember2024-03-310000104889srt:MinimumMemberus-gaap:DatabasesMember2023-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2023-12-310000104889srt:MaximumMemberus-gaap:DatabasesMember2024-03-310000104889us-gaap:DatabasesMember2024-03-310000104889us-gaap:DatabasesMember2023-12-310000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2024-03-310000104889srt:MinimumMemberus-gaap:OtherIntangibleAssetsMember2023-12-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2024-03-310000104889srt:MaximumMemberus-gaap:OtherIntangibleAssetsMember2023-12-310000104889us-gaap:OtherIntangibleAssetsMember2024-03-310000104889us-gaap:OtherIntangibleAssetsMember2023-12-310000104889us-gaap:FranchiseRightsMember2024-03-310000104889us-gaap:FranchiseRightsMember2023-12-310000104889us-gaap:TrademarksAndTradeNamesMember2024-03-310000104889us-gaap:TrademarksAndTradeNamesMember2023-12-310000104889us-gaap:OperatingAndBroadcastRightsMember2024-03-310000104889us-gaap:OperatingAndBroadcastRightsMember2023-12-310000104889us-gaap:OtherIntangibleAssetsMember2024-03-310000104889us-gaap:OtherIntangibleAssetsMember2023-12-310000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2024-03-310000104889ghc:FivePointSevenFivePercentUnsecuredNotesMaturingIn2026Member2023-12-310000104889srt:MinimumMemberghc:FiveYearCreditAgreementMaturingIn2027Member2024-03-310000104889srt:MaximumMemberghc:FiveYearCreditAgreementMaturingIn2027Member2024-03-310000104889ghc:FiveYearCreditAgreementMaturingIn2027Member2024-03-310000104889ghc:FiveYearCreditAgreementMaturingIn2027Member2023-12-310000104889srt:MinimumMemberghc:TermLoanMaturingIn2027150MillionMember2024-03-310000104889srt:MaximumMemberghc:TermLoanMaturingIn2027150MillionMember2024-03-310000104889ghc:TermLoanMaturingIn2027150MillionMember2024-03-310000104889ghc:TermLoanMaturingIn2027150MillionMember2023-12-310000104889ghc:RealEstateTermLoanMaturingIn2028752MillionMembersrt:MinimumMember2024-03-310000104889ghc:RealEstateTermLoanMaturingIn2028752MillionMembersrt:MaximumMember2024-03-310000104889ghc:RealEstateTermLoanMaturingIn2028752MillionMember2024-03-310000104889ghc:RealEstateTermLoanMaturingIn2028752MillionMember2023-12-310000104889ghc:CapitalTermLoanMaturingIn202865MillionMembersrt:MinimumMember2024-03-310000104889ghc:CapitalTermLoanMaturingIn202865MillionMembersrt:MaximumMember2024-03-310000104889ghc:CapitalTermLoanMaturingIn202865MillionMember2024-03-310000104889ghc:CapitalTermLoanMaturingIn202865MillionMember2023-12-310000104889srt:MinimumMemberghc:OtherIndebtednessMember2024-03-310000104889srt:MaximumMemberghc:OtherIndebtednessMember2024-03-310000104889ghc:USDRevolvingCreditFacilityBorrowingsMember2024-03-310000104889ghc:USDRevolvingCreditFacilityBorrowingsMemberghc:SecuredOvernightFinancingRatesSOFRMember2024-01-012024-03-310000104889ghc:USDRevolvingCreditFacilityBorrowingsMemberus-gaap:PrimeRateMember2024-01-012024-03-310000104889ghc:GBPRevolvingCreditFacilityBorrowingsMember2024-03-310000104889ghc:SterlingOvernightInterbankAverageRateSONIAMemberghc:GBPRevolvingCreditFacilityBorrowingsMember2024-01-012024-03-310000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMemberghc:GrahamHealthcareGroupMember2024-01-012024-03-310000104889us-gaap:SecuritiesSubjectToMandatoryRedemptionMemberghc:GrahamHealthcareGroupMember2023-01-012023-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-03-310000104889us-gaap:FairValueMeasurementsRecurringMember2024-03-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2023-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310000104889us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-12-310000104889us-gaap:FairValueMeasurementsRecurringMember2023-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2023-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2023-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2024-01-012024-03-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2024-01-012024-03-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2024-03-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2024-03-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2022-12-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2023-01-012023-03-310000104889ghc:ContingentConsiderationLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310000104889us-gaap:FairValueInputsLevel3Memberghc:MandatorilyRedeemableNoncontrollingInterestMember2023-03-310000104889country:US2024-01-012024-03-310000104889country:US2023-01-012023-03-310000104889us-gaap:NonUsMember2024-01-012024-03-310000104889us-gaap:NonUsMember2023-01-012023-03-310000104889us-gaap:TransferredOverTimeMember2024-01-012024-03-310000104889us-gaap:TransferredAtPointInTimeMember2024-01-012024-03-310000104889us-gaap:TransferredOverTimeMember2023-01-012023-03-310000104889us-gaap:TransferredAtPointInTimeMember2023-01-012023-03-310000104889ghc:KaplanInternationalMember2024-03-310000104889us-gaap:LongTermContractWithCustomerMember2024-04-01ghc:KaplanInternationalMember2024-03-310000104889ghc:KaplanInternationalMember2023-12-310000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2024-01-012024-03-310000104889us-gaap:LongTermContractWithCustomerMember2024-04-01ghc:SupplementalEducationMember2024-03-310000104889us-gaap:LongTermContractWithCustomerMemberghc:SupplementalEducationMember2024-03-310000104889us-gaap:EmployeeStockOptionMember2024-01-012024-03-310000104889us-gaap:EmployeeStockOptionMember2023-01-012023-03-310000104889us-gaap:RestrictedStockMember2024-01-012024-03-310000104889us-gaap:RestrictedStockMember2023-01-012023-03-310000104889us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000104889us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000104889ghc:SeparationIncentiveProgramMemberus-gaap:PensionPlansDefinedBenefitMemberghc:FramebridgeMember2024-01-012024-03-310000104889ghc:LeafGroupAndCode3Memberghc:SeparationIncentiveProgramMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2024-01-012024-03-310000104889us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember2023-01-012023-03-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesUsMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889us-gaap:PrivateEquityFundsMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:FixedIncomeSecuritiesUSMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889ghc:EquityFundsUSMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:EquityFundsUSMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889us-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889us-gaap:PensionPlansDefinedBenefitMember2023-12-31ghc:company0000104889ghc:InvestmentManager1Memberghc:AlphabetAndBerkshireHathawayCommonStockMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000104889srt:MaximumMemberghc:InvestmentManager1Memberghc:ForeignInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:InvestmentManager2Memberghc:BerkshireHathawayCommonStockMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000104889ghc:InvestmentManager2Membersrt:MaximumMemberghc:ForeignInvestmentsMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:InvestmentManager2Membersrt:MinimumMemberus-gaap:FixedIncomeSecuritiesMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000104889ghc:DefinedBenefitPlanAssetsTotalMemberghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberus-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000104889us-gaap:EquitySecuritiesMemberghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-31ghc:investment0000104889us-gaap:PrivateEquityFundsMemberghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889us-gaap:USTreasurySecuritiesMemberghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889us-gaap:EquitySecuritiesMemberghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889us-gaap:PrivateEquityFundsMemberghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889ghc:DefinedBenefitPlanAssetsTotalMemberghc:ConcentrationInSingleEntityTypeOfIndustryForeignCountryOrIndividualFundMemberus-gaap:PensionPlansDefinedBenefitMember2023-01-012023-12-310000104889ghc:SingleEquityConcentrationMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889ghc:MarkelGroupIncMemberus-gaap:PensionPlansDefinedBenefitMember2024-03-310000104889ghc:MarkelGroupIncMemberus-gaap:PensionPlansDefinedBenefitMember2023-12-310000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310000104889us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310000104889ghc:KaplanUniversityTransactionMemberghc:HigherEducationMemberghc:EducationMember2024-01-012024-03-310000104889ghc:KaplanUniversityTransactionMemberghc:HigherEducationMemberghc:EducationMember2023-01-012023-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2024-01-012024-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-01-012023-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-01-012024-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-012023-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-03-310000104889us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000104889us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000104889us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310000104889us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000104889us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-31ghc:claim0000104889srt:MaximumMember2024-03-31ghc:segment0000104889ghc:KaplanUniversityTransactionMemberghc:HigherEducationMemberghc:EducationMemberghc:PurdueUniversityGlobalMember2024-03-310000104889ghc:KaplanUniversityTransactionMemberghc:HigherEducationMemberghc:EducationMemberghc:PurdueUniversityGlobalMember2018-03-222018-03-220000104889ghc:AutomotiveMemberus-gaap:RelatedPartyMember2024-01-012024-03-310000104889ghc:AutomotiveMemberus-gaap:RelatedPartyMember2023-01-012023-03-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889us-gaap:CorporateNonSegmentMember2024-01-012024-03-310000104889us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000104889us-gaap:IntersegmentEliminationMember2024-01-012024-03-310000104889us-gaap:IntersegmentEliminationMember2023-01-012023-03-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:EducationMemberus-gaap:OperatingSegmentsMember2023-12-310000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:TelevisionBroadcastingMemberus-gaap:OperatingSegmentsMember2023-12-310000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:ManufacturingMemberus-gaap:OperatingSegmentsMember2023-12-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:GrahamHealthcareGroupMemberus-gaap:OperatingSegmentsMember2023-12-310000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:AutomotiveMemberus-gaap:OperatingSegmentsMember2023-12-310000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2024-03-310000104889us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-12-310000104889us-gaap:CorporateNonSegmentMember2024-03-310000104889us-gaap:CorporateNonSegmentMember2023-12-310000104889ghc:KaplanInternationalMemberus-gaap:ReportableSubsegmentsMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:KaplanInternationalMemberus-gaap:ReportableSubsegmentsMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889us-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889us-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889us-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889us-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:KaplanCorporateAndOtherMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:KaplanCorporateAndOtherMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000104889ghc:EducationMemberus-gaap:IntersubsegmentEliminationsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000104889ghc:KaplanInternationalMemberus-gaap:ReportableSubsegmentsMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:KaplanInternationalMemberus-gaap:ReportableSubsegmentsMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-12-310000104889us-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-03-310000104889us-gaap:ReportableSubsegmentsMemberghc:HigherEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-12-310000104889us-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-03-310000104889us-gaap:ReportableSubsegmentsMemberghc:SupplementalEducationMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-12-310000104889ghc:KaplanCorporateAndOtherMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2024-03-310000104889ghc:KaplanCorporateAndOtherMemberghc:EducationMemberus-gaap:OperatingSegmentsMember2023-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended March 31, 2024
or
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number 001-06714
GRAHAM HOLDINGS COMPANY
(Exact name of registrant as specified in its charter)
Delaware53-0182885
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1300 North 17th Street, Arlington, Virginia

22209
(Address of principal executive offices)(Zip Code)
(703) 345-6300
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class B Common Stock, par value $1.00 per share GHCNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  .    No  .
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  .    No  .  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated
filer
Non-accelerated
filer
Smaller reporting
company
Emerging growth
company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  .    No  .  
Shares outstanding at April 26, 2024:
Class A Common Stock – 964,001 Shares
Class B Common Stock – 3,473,761 Shares



GRAHAM HOLDINGS COMPANY
Index to Form 10-Q
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 















Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
Item 2.
Item 5.
Item 6.
 
 



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
  Three Months Ended 
 March 31
  
(in thousands, except per share amounts)20242023
Operating Revenues
Sales of services$646,410 $586,863 
Sales of goods506,252 444,683 
1,152,662 1,031,546 
Operating Costs and Expenses  
Cost of services sold (exclusive of items shown below)387,743 356,942 
Cost of goods sold (exclusive of items shown below)432,220 370,272 
Selling, general and administrative263,979 241,962 
Depreciation of property, plant and equipment22,527 20,025 
Amortization of intangible assets10,751 13,944 
Impairment of long-lived assets 745 
  1,117,220 1,003,890 
Income from Operations
35,442 27,656 
Equity in earnings of affiliates, net
2,331 4,661 
Interest income2,178 1,204 
Interest expense(19,328)(14,294)
Non-operating pension and postretirement benefit income, net42,417 31,845 
Gain on marketable equity securities, net
104,152 18,022 
Other income, net1,647 3,083 
Income Before Income Taxes
168,839 72,177 
Provision for Income Taxes
43,500 19,200 
Net Income
125,339 52,977 
Net Income Attributable to Noncontrolling Interests(959)(705)
Net Income Attributable to Graham Holdings Company Common Stockholders
$124,380 $52,272 
Per Share Information Attributable to Graham Holdings Company Common Stockholders
    
Basic net income per common share
$27.87 $10.91 
Basic average number of common shares outstanding4,432 4,759 
Diluted net income per common share
$27.72 $10.88 
Diluted average number of common shares outstanding4,457 4,776 
See accompanying Notes to Condensed Consolidated Financial Statements.
1


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
  Three Months Ended 
 March 31
(in thousands)20242023
Net Income$125,339 $52,977 
Other Comprehensive Loss, Before Tax  
Foreign currency translation adjustments:  
Translation adjustments arising during the period(13,284)8,994 
Pension and other postretirement plans:    
Amortization of net prior service (credit) cost included in net income
(494)409 
Amortization of net actuarial gain included in net income
(12,987)(10,766)
  (13,481)(10,357)
Cash flow hedges gain (loss)1,111 (930)
Other Comprehensive Loss, Before Tax(25,654)(2,293)
Income tax benefit related to items of other comprehensive loss
3,162 2,878 
Other Comprehensive (Loss) Income, Net of Tax(22,492)585 
Comprehensive Income102,847 53,562 
Comprehensive income attributable to noncontrolling interests
(959)(705)
Total Comprehensive Income Attributable to Graham Holdings Company$101,888 $52,857 

See accompanying Notes to Condensed Consolidated Financial Statements.
2


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED BALANCE SHEETS
As of
(in thousands)March 31,
2024
December 31,
2023
  (Unaudited)  
Assets    
Current Assets    
Cash and cash equivalents$130,860 $169,897 
Restricted cash48,123 31,994 
Investments in marketable equity securities and other investments802,943 697,028 
Accounts receivable, net500,326 525,087 
Inventories and contracts in progress326,658 297,211 
Prepaid expenses137,395 119,933 
Income taxes receivable2,803 6,848 
Other current assets1,758 1,298 
Total Current Assets1,950,866 1,849,296 
Property, Plant and Equipment, Net548,279 560,314 
Lease Right-of-Use Assets395,969 409,183 
Investments in Affiliates186,674 186,480 
Goodwill, Net1,513,316 1,525,194 
Indefinite-Lived Intangible Assets187,319 187,862 
Amortized Intangible Assets, Net101,626 112,194 
Prepaid Pension Cost2,129,682 2,113,638 
Deferred Income Taxes10,682 10,578 
Deferred Charges and Other Assets
230,715 232,991 
Total Assets$7,255,128 $7,187,730 
Liabilities and Equity    
Current Liabilities    
Accounts payable, vehicle floor plan payable and accrued liabilities$679,154 $694,521 
Deferred revenue387,076 396,754 
Income taxes payable30,291 7,406 
Current portion of lease liabilities60,709 64,247 
Current portion of long-term debt76,844 66,751 
Dividends declared7,674  
Total Current Liabilities1,241,748 1,229,679 
Accrued Compensation and Related Benefits128,829 137,275 
Other Liabilities32,254 32,076 
Deferred Income Taxes609,120 600,124 
Mandatorily Redeemable Noncontrolling Interest42,549 40,764 
Lease Liabilities367,213 376,677 
Long-Term Debt738,708 745,082 
Total Liabilities3,160,421 3,161,677 
Commitments and Contingencies (Note 14)
Redeemable Noncontrolling Interests24,225 24,185 
Preferred Stock  
Common Stockholders’ Equity    
Common stock20,000 20,000 
Capital in excess of par value373,367 372,040 
Retained earnings7,446,491 7,337,463 
Accumulated other comprehensive income, net of taxes  
Cumulative foreign currency translation adjustment(45,995)(32,711)
Unrealized gain on pensions and other postretirement plans639,155 649,185 
Cash flow hedges(1,315)(2,137)
Cost of Class B common stock held in treasury(4,388,213)(4,368,103)
Total Common Stockholders’ Equity4,043,490 3,975,737 
Noncontrolling Interests26,992 26,131 
Total Equity4,070,482 4,001,868 
Total Liabilities and Equity$7,255,128 $7,187,730 
See accompanying Notes to Condensed Consolidated Financial Statements.
3


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
  Three Months Ended 
 March 31
(in thousands)20242023
Cash Flows from Operating Activities    
Net Income$125,339 $52,977 
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and long-lived asset impairments33,278 34,714 
Amortization of lease right-of-use asset16,866 16,492 
Net pension benefit and special separation benefit expense(29,056)(23,162)
Gain on marketable equity securities and cost method investments, net(103,746)(19,853)
Gain on disposition of property, plant and equipment and investments, net(487)(1,053)
Credit loss expense and provision for other receivables1,696 15 
Stock-based compensation expense, net of forfeitures1,444 1,802 
Foreign exchange (gain) loss(617)1,504 
Equity in earnings of affiliates, net of distributions
(131)(4,655)
Provision for (benefit from) deferred income taxes12,255 (1,781)
Change in operating assets and liabilities:
Accounts receivable21,523 47,244 
Inventories(28,754)(19,318)
Accounts payable and accrued liabilities(43,762)(48,264)
Deferred revenue(1,130)4,614 
Income taxes receivable/payable27,161 17,274 
Lease liabilities(16,424)(16,182)
Other assets and other liabilities, net(14,958)(18,800)
Other570 (757)
Net Cash Provided by Operating Activities1,067 22,811 
Cash Flows from Investing Activities    
Purchases of property, plant and equipment(21,258)(22,554)
Investments in equity affiliates and cost method investments
(526)(4,735)
Net proceeds from disposition of property, plant and equipment and investments
495 2,706 
Proceeds from sales of marketable equity securities 29,028 
Purchases of marketable equity securities (6,162)
Other 327 (237)
Net Cash Used in Investing Activities(20,962)(1,954)
Cash Flows from Financing Activities    
Net proceeds from vehicle floor plan payable26,803 7,196 
Common shares repurchased(20,028)(23,439)
Net borrowings (payments) under revolving credit facilities9,245 (33,000)
Dividends paid(7,678)(7,910)
Repayments of borrowings(4,902)(3,999)
Proceeds from bank overdrafts757 3,153 
Other(2,671)197 
Net Cash Provided by (Used in) Financing Activities1,526 (57,802)
Effect of Currency Exchange Rate Change(4,539)1,235 
Net Decrease in Cash and Cash Equivalents and Restricted Cash(22,908)(35,710)
Beginning Cash and Cash Equivalents and Restricted Cash201,891 190,432 
Ending Cash and Cash Equivalents and Restricted Cash$178,983 $154,722 


See accompanying Notes to Condensed Consolidated Financial Statements.
4


GRAHAM HOLDINGS COMPANY
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN COMMON STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2023$20,000 $372,040 $7,337,463 $614,337 $(4,368,103)$26,131 $4,001,868 $24,185 
Net income for the period125,339 125,339 
Net income attributable to noncontrolling interests(633)633  
Net income attributable to redeemable noncontrolling interests
(326)(326)326 
Change in redemption value of redeemable noncontrolling interests284 284 164 
Noncontrolling interest capital contribution200 200 
Distributions to noncontrolling interests(256)(256)(450)
Dividends on common stock(15,352)(15,352)
Repurchase of Class B common stock(20,227)(20,227)
Issuance of Class B common stock, net of restricted stock award forfeitures(344)117 (227)
Amortization of unearned stock compensation and stock option expense1,671 1,671 
Other comprehensive loss, net of income taxes(22,492)(22,492)
As of March 31, 2024$20,000 $373,367 $7,446,491 $591,845 $(4,388,213)$26,992 $4,070,482 $24,225 
(in thousands)Common
Stock
Capital in
Excess of
Par Value
Retained
Earnings
Accumulated Other Comprehensive IncomeTreasury
Stock
Noncontrolling
Interest
Total EquityRedeemable Noncontrolling Interest
As of December 31, 2022$20,000 $390,438 $7,163,128 $336,151 $(4,178,334)$21,278 $3,752,661 $21,827 
Net income for the period52,977 52,977 
Net Income attributable to noncontrolling interests(650)650  
Net income attributable to redeemable noncontrolling interests
(55)(55)55 
Change in redemption value of redeemable noncontrolling interests64 64 70 
Noncontrolling interest capital contribution520 520 
Distribution to redeemable noncontrolling interest (70)
Dividends on common stock(15,812)(15,812)
Repurchase of Class B common stock(23,439)(23,439)
Issuance of Class B common stock(4,067)4,494 427 
Amortization of unearned stock compensation and stock option expense1,802 1,802 
Other comprehensive income, net of income taxes585 585 
As of March 31, 2023$20,000 $388,173 $7,199,588 $336,736 $(4,197,279)$22,512 $3,769,730 $21,882 

See accompanying Notes to Condensed Consolidated Financial Statements.
5


GRAHAM HOLDINGS COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. ORGANIZATION, BASIS OF PRESENTATION AND RECENT ACCOUNTING PRONOUNCEMENTS
Graham Holdings Company (the Company), is a diversified holding company whose operations include educational services, television broadcasting, manufacturing, healthcare, automotive dealerships and other businesses.
Through Kaplan, Inc. (Kaplan), the Company provides a wide variety of educational services to students, schools, colleges, universities and businesses, both domestically and outside the United States (U.S.), including academic preparation programs for international students, English-language programs, operations support services for pre-college, certificate, undergraduate and graduate programs, exam preparation for high school and graduate students and for professional certifications and licensures, career and academic advisement services to businesses, and operates a United Kingdom (U.K.) sixth-form college that prepares students for A-level examinations.
The Company’s television broadcasting segment owns and operates seven television broadcasting stations and provides social media management tools designed to connect newsrooms with their users.
The Company’s manufacturing companies comprise the ownership of a supplier of pressure treated wood, a manufacturer of electrical solutions, a manufacturer of lifting solutions, and a supplier of parts used in electric utilities and industrial systems.
The Company’s healthcare segment provides home health, hospice and palliative services, in-home specialty pharmacy infusion therapies, applied behavior analysis therapy, physician services for allergy, asthma and immunology patients, in-home aesthetics, and healthcare software-as-a-service technology.
The Company’s automotive business comprises eight dealerships and valet repair services.
The Company’s other businesses include an online art gallery and in-person art fair business; an online commerce platform featuring original art and designs on an array of consumer products; an owner and operator of websites; restaurants; a custom framing company; a marketing solutions provider; a customer data and analytics software company; Slate and Foreign Policy magazines; and a daily local news podcast and newsletter company.
Basis of Presentation – The accompanying condensed consolidated financial statements have been prepared in accordance with: (i) generally accepted accounting principles in the United States of America (GAAP) for interim financial information; (ii) the instructions to Form 10-Q; and (iii) the guidance of Rule 10-01 of Regulation S-X under the Securities and Exchange Act of 1934, as amended, for financial statements required to be filed with the Securities and Exchange Commission (SEC). They include the assets, liabilities, results of operations and cash flows of the Company, including its domestic and foreign subsidiaries that are more than 50% owned or otherwise controlled by the Company. As permitted under such rules, certain notes and other financial information normally required by GAAP have been condensed or omitted. Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company’s financial position, results of operations, and cash flows as of and for the periods presented herein. The Company’s results of operations for the three months ended March 31, 2024 and 2023 may not be indicative of the Company’s future results. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Revision of Prior Period Amounts. In the fourth quarter of 2023, the Company identified misstatements in its previously issued Condensed Consolidated Balance Sheets which had a related impact to the changes in assets and liabilities within operating cash flows. The Company determined that these adjustments were not material to the previously issued financial statements, but has revised its previously issued Condensed Consolidated Statement of Cash Flows for the period ended March 31, 2023 as shown below.
Three Months Ended March 31, 2023
(In thousands)As Previously ReportedAdjustmentsAs Revised
Change in operating assets and liabilities:
Accounts receivable$54,245 $(7,001)$47,244 
Deferred revenue(2,387)7,001 4,614 
Net Cash Provided by Operating Activities$22,811 $ $22,811 
6


Use of Estimates in the Preparation of the Condensed Consolidated Financial Statements – The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported herein. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates.
Recently Adopted and Issued Accounting Pronouncements – In November 2023, the FASB issued new guidance that requires enhanced disclosures related to reportable segments that includes, among other disclosures, identifying significant segment expenses on an annual and interim basis. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted and the guidance must be applied retrospectively to all prior periods presented in the financial statements. The Company is in the process of evaluating the impact of this new guidance on the disclosures within its Condensed Consolidated Financial Statements.
In December 2023, the FASB issued new guidance that requires enhanced income tax disclosures related to the rate reconciliation, information on income taxes paid and other items. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The standard permits both prospective and retrospective application. The Company is in the process of evaluating the impact of this new guidance on the disclosures within its Condensed Consolidated Financial Statements.
2. ACQUISITIONS AND DISPOSITIONS OF BUSINESSES
Acquisitions. In January 2024, the Company acquired one small business which is included in other businesses.
During 2023, the Company acquired five businesses: three in healthcare, one in automotive, and one in other businesses for $83.3 million in cash and contingent consideration and the assumption of floor plan payables. The assets and liabilities of the companies acquired were recorded at their estimated fair values at the date of acquisition.
In January 2023, Graham Healthcare Group (GHG) acquired two small businesses which are included in healthcare.
In July 2023, the Company acquired one small business which is included in other businesses.
In September 2023, the Company’s automotive subsidiary acquired a Toyota automotive dealership, including the real property for the dealership operations. In addition to a cash payment and the assumption of $2.2 million in floor plan payables, the automotive subsidiary borrowed $37.0 million to finance the acquisition. The dealership is operated and managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships. This acquisition expands the Company’s automotive business operations and is included in automotive.
In December 2023, GHG acquired one small business which is included in healthcare.
7


Acquisition-related costs for acquisitions that closed during the first three months of 2024 and 2023 were expensed as incurred. The aggregate purchase price of the 2023 acquisitions was allocated as follows, based on acquisition date fair values to the following assets and liabilities:
Purchase Price Allocation
Year Ended
(in thousands)December 31, 2023
Accounts receivable$68 
Inventory5,224 
Property, plant and equipment29,859 
Goodwill45,968 
Indefinite-lived intangible assets6,300 
Amortized intangible assets235 
Other assets4 
Floor plan payables(2,215)
Other liabilities(935)
Current and noncurrent lease liabilities(1,184)
Aggregate purchase price, net of cash acquired$83,324 
Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. The goodwill recorded due to these acquisitions is attributable to the assembled workforces of the acquired companies and expected synergies. The Company expects to deduct $45.0 million of goodwill for income tax purposes for the acquisitions completed in 2023.
The acquired companies were consolidated into the Company’s financial statements starting on their respective acquisition dates. The following unaudited pro forma financial information includes the 2023 acquisitions as if they occurred at the beginning of 2022:
Three Months Ended 
 March 31
(in thousands)2023
Operating revenues$1,069,299 
Net income54,694 
These pro forma results were based on estimates and assumptions, which the Company believes are reasonable, and include the historical results of operations of the acquired companies and adjustments for depreciation and amortization of identified assets and the effect of pre-acquisition transaction related expenses incurred by the Company and the acquired entities. The pro forma information does not include efficiencies, cost reductions and synergies expected to result from the acquisitions. They are not the results that would have been realized had these entities been part of the Company during the periods presented and are not necessarily indicative of the Company’s consolidated results of operations in future periods.
Disposition of Businesses. In June 2023, the Company entered into an agreement to merge the Pinna business with Realm of Possibility, Inc. (Realm) in return for an additional noncontrolling financial interest in Realm (the Pinna transaction). The Company deconsolidated the Pinna subsidiary, which was included in other businesses, and continues to account for its interest in Realm under the equity method of accounting (see Note 3).
Other Transactions. In December 2023, the Company acquired some of the minority-owned shares of CSI Pharmacy Holding Company, LLC (CSI) for a total amount of $20.0 million. The Company paid cash of $5.0 million and entered into a promissory note with the minority owners for the remaining $15.0 million at an interest rate of 8% per annum. The note is included in other indebtedness (see Note 7) and payable in quarterly installments with the final payment due by January 1, 2027. Following the redemption, the Company owns 86.7% of CSI.
3. INVESTMENTS
Money Market Investments. As of March 31, 2024 and December 31, 2023, the Company had money market investments of $7.5 million and $5.6 million, respectively, that are classified as cash and cash equivalents in the Company’s Condensed Consolidated Balance Sheets.
8


Investments in Marketable Equity Securities. Investments in marketable equity securities consist of the following:
  As of
March 31,
2024
December 31,
2023
(in thousands)
Total cost
$225,971 $225,971 
Gross unrealized gains
568,334 464,182 
Total Fair Value
$794,305 $690,153 
At March 31, 2024 and December 31, 2023, the Company owned 55,430 shares in Markel Group Inc. (Markel) valued at $84.3 million and $78.7 million, respectively. The Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company’s Board of Directors. As of March 31, 2024, the Company owned 422 Class A and 482,945 Class B shares in Berkshire Hathaway valued at $470.8 million, which exceeded 5% of the Company’s total assets.
There were no purchases of marketable equity securities during the first three months of 2024. The Company purchased $4.6 million of marketable equity securities during the first three months of 2023.
There were no sales of marketable equity securities during the first three months of 2024. During the first three months of 2023, the gross cumulative realized net losses from the sales of marketable equity securities were $12.2 million. The total proceeds from such sales were $29.0 million.
The net gain on marketable equity securities comprised the following:

Three Months Ended 
 March 31
(in thousands)
20242023
Gain on marketable equity securities, net
$104,152 $18,022 
Less: Net losses in earnings from marketable equity securities sold
 3,657 
Net unrealized gains in earnings from marketable equity securities still held at the end of the period
$104,152 $21,679 
Investments in Affiliates. As of March 31, 2024, the Company held a 49.9% and 42.2% interest in N2K Networks and Realm, respectively, on a fully diluted basis, and accounts for these investments under the equity method. The Company holds two of the five seats of N2K Networks’ governing board with the other shareholders retaining substantive participation rights to control the financial and operating decisions of N2K Networks through representation on the board.
As of March 31, 2024, the Company held an approximate 18% interest in Intersection Holdings, LLC (Intersection), and accounts for its investment under the equity method. The Company holds two of the ten seats of Intersection’s governing board, which allows the Company to exercise significant influence over Intersection. The Company loaned Intersection $30.0 million, which is repayable over 5 years at an interest rate of 9% per annum. The outstanding balance on this loan was $28.3 million as of March 31, 2024. The loan is repayable by May 2028.
As of March 31, 2024, the Company also held investments in several other affiliates; GHG held a 40% interest in each of the following affiliates: Residential Home Health Illinois, Residential Hospice Illinois, Mary Free Bed at Home, and Allegheny Health Network (AHN) Healthcare at Home. For the three months ended March 31, 2024 and 2023, the Company recorded $4.1 million and $3.5 million, respectively, in revenue for services provided to the affiliates of GHG.
Additionally, Kaplan International Holdings Limited (KIHL) held a 45% interest in a joint venture formed with University of York. KIHL loaned the joint venture £22 million, which is repayable over 25 years at an interest rate of 7% and guaranteed by the University of York. The outstanding balance on this loan was £19.9 million as of March 31, 2024. The loan is repayable by December 2041.
The Company had $39.6 million and $36.9 million in its investment account that represents cumulative undistributed income in its investments in affiliates as of March 31, 2024 and December 31, 2023, respectively.
Cost Method Investments. The Company held investments without readily determinable fair values in a number of equity securities that are accounted for as cost method investments, which are recorded at cost, less impairment, and adjusted for observable price changes for identical or similar investments of the same issuer. The carrying value of these investments was $74.0 million as of March 31, 2024 and December 31, 2023. During the three months ended March 31, 2024, the Company recorded impairment losses of $0.4 million to those securities. During
9


the three months ended March 31, 2023, the Company recorded gains of $1.8 million to those equity securities based on observable transactions.
4. ACCOUNTS RECEIVABLE, ACCOUNTS PAYABLE, VEHICLE FLOOR PLAN PAYABLE AND ACCRUED LIABILITIES
Accounts receivable consist of the following:
As of
March 31,
2024
December 31,
2023
(in thousands)
Receivables from contracts with customers, less estimated credit losses of $26,447 and $24,667
$468,371 $496,172 
Other receivables31,955 28,915 
 $500,326 $525,087 
Credit loss expense was $1.7 million and $0.5 million for the three months ended March 31, 2024 and 2023, respectively.
Accounts payable, vehicle floor plan payable and accrued liabilities consist of the following:
As of
March 31,
2024
December 31,
2023
(in thousands)
Accounts payable$137,697 $154,484 
Vehicle floor plan payable175,103 148,300 
Accrued compensation and related benefits136,076 154,580 
Other accrued liabilities230,278 237,157 
$679,154 $694,521 
Cash overdrafts of $1.3 million and $0.5 million are included in accounts payable as of March 31, 2024 and December 31, 2023, respectively.
The Company finances new, used and service loaner vehicle inventory through standardized floor plan facilities with Truist Bank and Toyota Motor Credit Corporation (Truist and Toyota floor plan facility) and Ford Motor Credit Company (Ford floor plan facility). At March 31, 2024, the floor plan facilities bore interest at variable rates that are based on Secured Overnight Financing Rate (SOFR) and prime-based interest rates. The weighted average interest rate for the floor plan facilities was 6.9% and 5.4% for the three months ended March 31, 2024 and 2023, respectively. Changes in the vehicle floor plan payable are reported as cash flows from financing activities in the Condensed Consolidated Statements of Cash Flows.
The floor plan facilities are collateralized by vehicle inventory and other assets of the relevant dealership subsidiary, and contain a number of covenants, including, among others, covenants restricting the dealership subsidiary with respect to the creation of liens and changes in ownership, officers and key management personnel. The Company was in compliance with all of these restrictive covenants as of March 31, 2024.
The floor plan interest expense related to the vehicle floor plan arrangements is offset by amounts received from manufacturers in the form of floor plan assistance capitalized in inventory and recorded against cost of goods sold in the Condensed Consolidated Statements of Operations when the associated inventory is sold. For the three months ended March 31, 2024 and 2023, the Company recognized a reduction in cost of goods sold of $2.2 million and $1.4 million, respectively, related to manufacturer floor plan assistance.
As of March 31, 2024 and December 31, 2023, the Company had $156.9 million and $128.9 million, respectively, in obligations outstanding related to floor plan facilities associated with new vehicles.
10


5. INVENTORIES AND CONTRACTS IN PROGRESS
Inventories and contracts in progress consist of the following:
As of
March 31,
2024
December 31,
2023
(in thousands)
Raw materials$62,833 $63,884 
Work-in-process17,214 15,387 
Finished goods243,335 215,283 
Contracts in progress3,276 2,657 
 $326,658 $297,211 
6. GOODWILL AND OTHER INTANGIBLE ASSETS
Amortization of intangible assets for the three months ended March 31, 2024 and 2023, was $10.8 million and $13.9 million, respectively. Amortization of intangible assets is estimated to be approximately $27 million for the remainder of 2024, $29 million in 2025, $20 million in 2026, $6 million in 2027, $3 million in 2028 and $17 million thereafter.
The changes in the carrying amount of goodwill, by segment, were as follows:
(in thousands)EducationTelevision
Broadcasting
ManufacturingHealthcareAutomotiveOther
Businesses
Total
Balance as of December 31, 2023        
Goodwill$1,163,991 $190,815 $234,993 $135,038 $129,280 $251,216 $2,105,333 
Accumulated impairment losses
(331,151) (82,062)  (166,926)(580,139)
832,840 190,815 152,931 135,038 129,280 84,290 1,525,194 
Foreign currency exchange rate changes
(11,878)     (11,878)
Balance as of March 31, 2024        
Goodwill1,152,113 190,815 234,993 135,038 129,280 251,216 2,093,455 
Accumulated impairment losses
(331,151) (82,062)  (166,926)(580,139)
$820,962 $190,815 $152,931 $135,038 $129,280 $84,290 $1,513,316 
The changes in carrying amount of goodwill at the Company’s education division were as follows:
(in thousands)Kaplan
International
Higher
Education
Supplemental EducationTotal
Balance as of December 31, 2023      
Goodwill$598,000 $174,564 $391,427 $1,163,991 
Accumulated impairment losses (111,324)(219,827)(331,151)
598,000 63,240 171,600 832,840 
Foreign currency exchange rate changes(11,829) (49)(11,878)
Balance as of March 31, 2024      
Goodwill586,171 174,564 391,378 1,152,113 
Accumulated impairment losses (111,324)(219,827)(331,151)
$586,171 $63,240 $171,551 $820,962 
11


Other intangible assets consist of the following:
As of March 31, 2024As of December 31, 2023
(in thousands)Useful Life
Range
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
 Carrying
Amount
Amortized Intangible Assets              
Student and customer relationships
210 years
$282,190 $242,044 $40,146 $283,098 $236,776 $46,322 
Trade names and trademarks
215 years
143,163 93,733 49,430 143,389 90,558 52,831 
Network affiliation agreements
10 years
17,400 12,543 4,857 17,400 13,348 4,052 
Databases and technology
36 years
36,228 35,815 413 36,538 35,712 826 
Other
18 years
41,514 34,734 6,780 41,327 33,164 8,163 
    $520,495 $418,869 $101,626 $521,752 $409,558 $112,194 
Indefinite-Lived Intangible Assets
              
Franchise agreements$92,158 $92,158 
Trade names and trademarks  83,990     84,533     
FCC licenses11,000 11,000 
Other171 171 
  $187,319 $187,862 
7. DEBT
The Company’s borrowings consist of the following:
  As of
(in thousands)MaturitiesStated Interest RateEffective Interest RateMarch 31,
2024
December 31,
2023
Unsecured notes (1)
20265.75%5.75%$398,445 $398,266 
Revolving credit facility2027
6.56% - 8.88%
6.74%108,126 97,879 
Term loan (2)
2027
7.15% - 7.21%
7.30%145,559 147,476 
Real estate term loan (3)
2028
7.08% - 7.10%
7.19%73,605 74,541 
Capital term loan (4)
2028
7.33% - 7.35%
7.43%61,516 63,097 
Other indebtedness2024 - 2030
0.00% - 16.00%
28,301 30,574 
Total Debt815,552 811,833 
Less: current portion(76,844)(66,751)
Total Long-Term Debt$738,708 $745,082 
____________
(1)     The carrying value is net of $1.6 million and $1.7 million of unamortized debt issuance costs as of March 31, 2024 and December 31, 2023, respectively.
(2)     The carrying value is net of $0.7 million and $0.6 million of unamortized debt issuance costs as of March 31, 2024 and December 31, 2023, respectively.
(3)     The carrying value is net of $0.1 million of unamortized debt issuance costs as of March 31, 2024 and December 31, 2023.
(4)     The carrying value is net of $0.8 million of unamortized debt issuance costs as of March 31, 2024 and December 31, 2023.
At March 31, 2024 and December 31, 2023, the fair value of the Company’s 5.75% unsecured notes, based on quoted market prices (Level 2 fair value assessment), totaled $398.1 million and $400.4 million, respectively.
The outstanding balance on the Company’s $300 million unsecured revolving credit facility was $108.1 million as of March 31, 2024, consisting of U.S. dollar borrowings of $45 million with interest payable at SOFR plus 1.375% or prime rate plus 0.375%, and British Pound (GBP) borrowings of £50 million with interest payable at Daily Sterling Overnight Index Average (SONIA) plus 1.375%.
The fair value of the Company’s other debt, which is based on Level 2 inputs, approximates its carrying value as of March 31, 2024 and December 31, 2023. The Company is in compliance with all financial covenants of the revolving credit facility and term loans as of March 31, 2024.
During the three months ended March 31, 2024 and 2023, the Company had average borrowings outstanding of approximately $810.7 million and $735.0 million, respectively, at average annual interest rates of approximately 6.4% and 5.8%, respectively. During the three months ended March 31, 2024 and 2023, the Company incurred net interest expense of $17.2 million and $13.1 million, respectively.
During the three months ended March 31, 2024 and 2023, the Company recorded interest expense of $1.9 million and $1.5 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest. The fair
12


value of the mandatorily redeemable noncontrolling interest was based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined by reference to either a discounted cash flow or EBITDA multiple, which approximates fair value (Level 3 fair value assessment).
8. FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows:
As of March 31, 2024
(in thousands)Level 1Level 2Level 3Total
Assets      
Money market investments (1) 
$ $7,526 $ $7,526 
Marketable equity securities (2)
794,305   794,305 
Other current investments (3)
7,682 956  8,638 
Total Financial Assets
$801,987 $8,482 $ $810,469 
Liabilities
  
  
  
Contingent consideration liabilities (4)
$ $ $75 $75 
Interest rate swaps (5) 
 1,651  1,651 
Mandatorily redeemable noncontrolling interest (6)
  42,549 42,549 
Total Financial Liabilities
$ $1,651 $42,624 $44,275 

As of December 31, 2023
(in thousands)Level 1Level 2Level 3Total
Assets
  
  

  
Money market investments (1) 
$ $5,577 $ $5,577 
Marketable equity securities (2)
690,153   690,153 
Other current investments (3)
6,875   6,875 
Total Financial Assets
$697,028 $5,577 $ $702,605 
Liabilities
  
  

  
Contingent consideration liabilities (4)
$ $ $788 $788 
Interest rate swaps (5)
 2,761  2,761 
Foreign exchange swap (7)
 86  86 
Mandatorily redeemable noncontrolling interest (6)
  40,764 40,764 
Total Financial Liabilities
$ $2,847 $41,552 $44,399 
____________
(1)
The Company’s money market investments are included in cash and cash equivalents and the value considers the liquidity of the counterparty.
(2)
The Company’s investments in marketable equity securities are held in common shares of U.S. corporations that are actively traded on U.S. stock exchanges. Price quotes for these shares are readily available.
(3)
Includes U.S. Government Securities, corporate bonds, mutual funds and time deposits. These investments are valued using a market approach based on the quoted market prices of the security or inputs that include quoted market prices for similar instruments and are classified as either Level 1 or Level 2 in the fair value hierarchy.
(4)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities and Other Liabilities. The Company determined the fair value of the contingent consideration liabilities using either a Monte Carlo simulation, Black-Scholes model, or probability-weighted analysis depending on the type of target included in the contingent consideration requirements (revenue, EBITDA, client retention). All analyses included estimated financial projections for the acquired businesses and acquisition-specific discount rates.
(5)
Included in Other Liabilities. The Company utilized a market approach model using the notional amount of the interest rate swaps multiplied by the observable inputs of time to maturity and market interest rates.
(6)
The fair value of the mandatorily redeemable noncontrolling interest is based on the fair value of the underlying subsidiaries owned by GHC One and GHC Two, after taking into account any debt and other noncontrolling interests of its subsidiary investments. The fair value of the owned subsidiaries is determined using enterprise value analyses which include an equal weighing between guideline public company and discounted cash flow analyses.
(7)
Included in Accounts payable, vehicle floor plan payable and accrued liabilities, and valued based on a valuation model that calculates the differential between the contract price and the market-based forward rate.

13


The following tables provide a reconciliation of changes in the Company’s financial liabilities measured at fair value on a recurring basis, using Level 3 inputs:
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2023
$788 $40,764 
Changes in fair value (1)
 1,876 
Accretion of value included in net income (1)
6  
Settlements or distributions
(719)(91)
As of March 31, 2024
$75 $42,549 
(in thousands)Contingent consideration liabilitiesMandatorily redeemable noncontrolling interest
As of December 31, 2022$8,423 $30,845 
Acquisition of business220  
Changes in fair value (1)
 1,468 
Accretion of value included in net income (1)
315  
Settlements or distributions
(752)(4)
As of March 31, 2023$8,206 $32,309 
____________
(1)Changes in fair value and accretion of value of contingent consideration liabilities are included in Selling, general and administrative expenses and the changes in fair value of mandatorily redeemable noncontrolling interest is included in Interest expense in the Company’s Condensed Consolidated Statements of Operations.
During the three months ended March 31, 2024, the Company recorded impairment losses of $0.4 million to equity securities that are accounted for as cost method investments. During the three months ended March 31, 2023, the Company recorded gains of $1.8 million to equity securities that are accounted for as cost method investments based on observable transactions for identical or similar investments of the same issuer.
During the three months ended March 31, 2023, the Company recorded long-lived asset impairment charges of $0.7 million. The remeasurement of the long-lived assets is classified as a Level 3 fair value assessment due to the significance of unobservable inputs developed in the determination of the fair value. The Company used a discounted cash flow model to determine the estimated fair value of the long-lived assets and made estimates and assumptions regarding future cash flows and discount rates.
9. REVENUE FROM CONTRACTS WITH CUSTOMERS
The Company generated 78% and 79% of its revenue from U.S. domestic sales for the three months ended March 31, 2024 and 2023, respectively. The remaining 22% and 21% of revenue was generated from non-U.S. sales for the three months ended March 31, 2024 and 2023, respectively.
For the three months ended March 31, 2024, the Company recognized 54% of its revenue over time as control of the services and goods transferred to the customer, and the remaining 46% at a point in time, when the customer obtained control of the promised goods. For the three months ended March 31, 2023, the Company recognized 55% of its revenue over time, and the remaining 45% at a point in time.
Contract Assets. As of March 31, 2024, the Company recognized a contract asset of $34.5 million related to a contract at a Kaplan International business, which is included in Deferred Charges and Other Assets. The Company expects to recognize an additional $294.7 million related to the remaining performance obligation in the contract over the next five years. As of December 31, 2023, the contract asset was $39.8 million.
Deferred Revenue. The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance which includes some payments that are refundable due to the contractual right of the customer to cancel the agreement. As of March 31, 2024 and December 31, 2023, 15% and 20% of the Company’s deferred revenue consisted of prepaid amounts which are refundable. The following table presents the change in the Company’s deferred revenue balance:
As of
March 31,
2024
December 31,
2023
%
(in thousands)Change
Deferred revenue$392,754 $400,347 (2)
The majority of the change in the deferred revenue balance is related to the cyclical nature of services in the Kaplan international division. During the three months ended March 31, 2024, the Company recognized $207.1 million
14


related to the Company’s deferred revenue balance as of December 31, 2023, including $28.7 million of prepaid amounts which were refundable at the prior year-end.
Revenue allocated to remaining performance obligations represents deferred revenue amounts that will be recognized as revenue in future periods. As of March 31, 2024, the deferred revenue balance related to certain medical and nursing qualifications with an original contract length greater than twelve months at Kaplan Supplemental Education was $5.8 million. Kaplan Supplemental Education expects to recognize 67% of this revenue over the next twelve months and the remainder thereafter.
Costs to Obtain a Contract. The following table presents changes in the Company’s costs to obtain a contract asset:
(in thousands)Balance at
Beginning
of Period
Costs associated with new contractsLess: Costs amortized during the periodOtherBalance
at
End of
Period
2024$41,634 $17,832 $(21,016)$(906)$37,544 
The majority of other activity was related to currency translation adjustments for the three months ended March 31, 2024.
15


10. EARNINGS PER SHARE
The Company’s unvested restricted stock awards contain nonforfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. The diluted earnings per share computed under the two-class method is lower than the diluted earnings per share computed under the treasury stock method, resulting in the presentation of the lower amount in diluted earnings per share. The computation of the earnings per share under the two-class method excludes the income attributable to the unvested restricted stock awards from the numerator and excludes the dilutive impact of those underlying shares from the denominator.
The following reflects the Company’s net income and share data used in the basic and diluted earnings per share computations using the two-class method:
Three Months Ended 
 March 31
(in thousands, except per share amounts)20242023
Numerator:
Numerator for basic earnings per share:    
Net income attributable to Graham Holdings Company common stockholders
$124,380 $52,272 
Less: Dividends paid-common stock outstanding and unvested restricted shares
(15,352)(15,812)
Undistributed earnings 109,028 36,460 
Percent allocated to common stockholders (1)
99.33 %99.35 %
108,295 36,225 
Add: Dividends paid-common stock outstanding15,250 15,711 
Numerator for basic earnings per share$123,545 $51,936 
Add: Additional undistributed earnings due to dilutive stock options
4 1 
Numerator for diluted earnings per share$123,549 $51,937 
Denominator:    
Denominator for basic earnings per share:
Weighted average shares outstanding4,432 4,759 
Add: Effect of dilutive stock options25 17 
Denominator for diluted earnings per share4,457 4,776 
Graham Holdings Company Common Stockholders:    
Basic earnings per share
$27.87 $10.91 
Diluted earnings per share
$27.72 $10.88 
____________
Earnings per share amounts may not recalculate due to rounding.
Diluted earnings per share excludes the following weighted average potential common shares, as the effect would be antidilutive, as computed under the treasury stock method:
Three Months Ended 
 March 31
(in thousands)20242023
Weighted average restricted stock18 10 
The diluted earnings per share amounts for the three months ended March 31, 2024 and March 31, 2023 exclude the effects of 105,000 stock options and contingently issuable shares outstanding as their inclusion would have been antidilutive due to a market condition.
In the three months ended March 31, 2024 and 2023, the Company declared regular dividends totaling $3.44 and $3.30 per common share, respectively.
16


11. PENSION AND POSTRETIREMENT PLANS
Defined Benefit Plans. The total benefit arising from the Company’s defined benefit pension plans consists of the following components:
  Three Months Ended 
 March 31
(in thousands)20242023
Service cost$14,034 $9,243 
Interest cost11,194 11,534 
Expected return on assets(41,690)(38,338)
Amortization of prior service (credit) cost(494)410 
Recognized actuarial gain(12,518)(10,140)
Net Periodic Benefit(29,474)(27,291)
Special separation benefit expense
418 4,129 
Total Benefit$(29,056)$(23,162)
In the first quarter of 2024, the Company recorded $0.4 million in expenses related to a Separation Incentive Program (SIP) for certain Framebridge employees, which will be funded from the assets of the Company’s pension plans. In the first quarter of 2023, the Company recorded $4.1 million in expenses related to SIPs for certain Leaf and Code3 employees, which was funded from the assets of the Company’s pension plans.
The total cost arising from the Company’s Supplemental Executive Retirement Plan (SERP) consists of the following components:
  Three Months Ended 
 March 31
(in thousands)20242023
Service cost$287 $148 
Interest cost1,128 1,165 
Net Periodic Cost$1,415 $1,313 
Defined Benefit Plan Assets. The Company’s defined benefit pension obligations are funded by a portfolio made up of private investment funds, a U.S. stock index fund, and a relatively small number of stocks and high-quality fixed-income securities that are held by a third-party trustee. The assets of the Company’s pension plans were allocated as follows:
  As of
  March 31,
2024
December 31,
2023
  
U.S. equities54 %59 %
Private investment funds16 %17 %
International equities12 %14 %
U.S. fixed income18 %7 %
U.S. stock index fund %3 %
  100 %100 %
The Company manages approximately 49% of the pension assets internally, of which the majority is invested in private investment funds with the remaining investments in Berkshire Hathaway and Markel stock, a U.S. stock index fund, and short-term fixed-income securities. The remaining 51% of plan assets are managed by two investment companies. The goal of the investment managers is to produce moderate long-term growth in the value of these assets, while protecting them against large decreases in value. Both investment managers may invest in a combination of equity and fixed-income securities and cash. The managers are not permitted to invest in securities of the Company or in alternative investments. One investment manager cannot invest more than 15% of the assets at the time of purchase in the stock of Alphabet and Berkshire Hathaway, and no more than 35% of the assets it manages in specified international exchanges at the time the investment is made. The other investment manager cannot invest more than 20% of the assets at the time of purchase in the stock of Berkshire Hathaway, and no more than 15% of the assets it manages in specified international exchanges at the time the investment is made, and no less than 5% of the assets could be invested in fixed-income securities. Excluding the exceptions noted above, the investment managers cannot invest more than 10% of the assets in the securities of any other single issuer, except for obligations of the U.S. Government, without receiving prior approval from the Plan administrator.
In determining the expected rate of return on plan assets, the Company considers the relative weighting of plan assets, the historical performance of total plan assets and individual asset classes and economic and other
17


indicators of future performance. In addition, the Company may consult with and consider the input of financial and other professionals in developing appropriate return benchmarks.
The Company evaluated its defined benefit pension plan asset portfolio for the existence of significant concentrations (defined as greater than 10% of plan assets) of credit risk as of March 31, 2024. Types of concentrations that were evaluated include, but are not limited to, investment concentrations in a single entity, type of industry, foreign country and individual fund. At March 31, 2024, the pension plan held investments in one common stock, one private investment fund, and one U.S. Treasury securities fund that exceeded 10% of total plan assets, valued at $1,665.4 million, or approximately 51% of total plan assets. At December 31, 2023, the pension plan held investments in one common stock and one private investment fund that exceeded 10% of total plan assets, valued at $1,011.1 million, or approximately 34% of total plan assets. Assets also included $88.3 million and $82.4 million of Markel shares at March 31, 2024 and December 31, 2023, respectively.
Other Postretirement Plans. The total benefit arising from the Company’s other postretirement plans consists of the following components:
  Three Months Ended 
 March 31
(in thousands)20242023
Interest cost$14 $22 
Amortization of prior service credit (1)
Recognized actuarial gain(469)(626)
Net Periodic Benefit$(455)$(605)
12. OTHER NON-OPERATING INCOME
A summary of non-operating income is as follows:

Three Months Ended 
 March 31
(in thousands)
20242023
Gain on sale of business$875 $1,000 
Foreign currency gain (loss), net617 (1,504)
Impairment of a cost method investment
(406) 
Gain on sale of cost method investments
6 785 
Gain on a cost method investment 1,831 
Gain on sale of investment in affiliate 15 
Other gain, net555 956 
Total Other Non-Operating Income
$1,647 $3,083 
The gain on cost method investments result from observable price changes in the fair value of the underlying equity securities accounted for under the cost method (see Notes 3 and 8).
During the three months ended March 31, 2024 and 2023, the Company recorded contingent consideration gains of $0.9 million and $1.0 million, respectively, related to the disposition of Kaplan University (KU) in 2018.
13. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The other comprehensive (loss) income consists of the following components:
  Three Months Ended March 31
  20242023
  Before-TaxIncomeAfter-TaxBefore-TaxIncomeAfter-Tax
(in thousands)AmountTaxAmountAmountTaxAmount
Foreign currency translation adjustments:            
Translation adjustments arising during the period$(13,284)$ $(13,284)$8,994 $ $8,994 
Pension and other postretirement plans:            
Amortization of net prior service (credit) cost included in net income
(494)126 (368)409 (105)304 
Amortization of net actuarial gain included in net income
(12,987)3,325 (9,662)(10,766)2,769 (7,997)
  (13,481)3,451 (10,030)(10,357)2,664 (7,693)
Cash flow hedges:          
Gain (loss) for the period1,111 (289)822 (930)214 (716)
Other Comprehensive (Loss) Income$(25,654)$3,162 $(22,492)$(2,293)$2,878 $585 
18


The accumulated balances related to each component of other comprehensive income (loss) are as follows:
(in thousands, net of taxes)Cumulative
Foreign
Currency
Translation
Adjustment
Unrealized Gain
on Pensions
and Other
Postretirement
Plans
Cash Flow
Hedges
Accumulated
Other
Comprehensive
Income
Balance as of December 31, 2023$(32,711)$649,185 $(2,137)$614,337 
Other comprehensive (loss) income before reclassifications
(13,284) 947 (12,337)
Net amount reclassified from accumulated other comprehensive income (loss)
 (10,030)(125)(10,155)
Net other comprehensive (loss) income
(13,284)(10,030)822 (22,492)
Balance as of March 31, 2024$(45,995)$639,155 $(1,315)$591,845 
The amounts and line items of reclassifications out of Accumulated Other Comprehensive Income (Loss) are as follows:
  Three Months Ended 
 March 31
Affected Line Item in the Condensed Consolidated Statements of Operations
  
(in thousands)20242023
Pension and Other Postretirement Plans:    
Amortization of net prior service (credit) cost$(494)$409 (1)
Amortization of net actuarial gain(12,987)(10,766)(1)
  (13,481)(10,357)Before tax
  3,451 2,664 Provision for Income Taxes
  (10,030)(7,693)Net of Tax
Cash Flow Hedges(125)(174)Interest expense
Total reclassification for the period$(10,155)$(7,867)Net of Tax
____________
(1)    These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and postretirement plan cost (see Note 11) and are included in non-operating pension and postretirement benefit income in the Company’s Condensed Consolidated Statements of Operations.
14. CONTINGENCIES
Litigation, Legal and Other Matters.  The Company and its subsidiaries are subject to complaints and administrative proceedings and are defendants in various civil lawsuits that have arisen in the ordinary course of their businesses, including contract disputes; actions alleging negligence, libel, defamation and invasion of privacy; trademark, copyright and patent infringement; real estate lease and sublease disputes; violations of employment laws and applicable wage and hour laws; and statutory or common law claims involving current and former students and employees. Although the outcomes of the legal claims and proceedings against the Company cannot be predicted with certainty, based on currently available information, management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company’s business, financial condition, results of operations or cash flows. However, based on currently available information, management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $10 million.
15. BUSINESS SEGMENTS
In the second quarter of 2023, Kaplan modified its segment reporting for Kaplan India, a shared services center that supports Higher Education. Kaplan India was previously included in Kaplan corporate and other. Certain amounts in previously issued financial statements have been reclassified to conform to the current presentation.
The Company has seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, Manufacturing, Healthcare and Automotive.
As of March 31, 2024, Kaplan had a total outstanding accounts receivable balance of $105.9 million from Purdue Global related to amounts due for reimbursements for services, fees earned and a deferred fee. Included in this total, Kaplan has a $19.6 million long-term receivable balance due from Purdue Global at March 31, 2024, related to the advance of $20.0 million during the initial KU Transaction.
During the three months ended March 31, 2024 and 2023, the automotive group recorded expense of $2.0 million and $1.7 million, respectively, for operating and management services provided by Christopher J. Ourisman and his team of industry professionals.
19


The following tables summarize the financial information related to each of the Company’s business segments:
  Three Months Ended 
 March 31
(in thousands)20242023
Operating Revenues    
Education$422,598 $378,041 
Television broadcasting113,058 112,877 
Manufacturing101,903 114,584 
Healthcare128,201 102,059 
Automotive303,840 232,561 
Other businesses83,298 92,008 
Corporate office576  
Intersegment elimination(812)(584)
  $1,152,662 $1,031,546 
Income (Loss) from Operations before Amortization of Intangible Assets and Impairment of Long-Lived Assets




Education$33,561 $27,456 
Television broadcasting30,983 29,945 
Manufacturing6,189 12,190 
Healthcare6,727 3,890 
Automotive9,652 10,843 
Other businesses(26,283)(27,906)
Corporate office(14,636)(14,073)
$46,193 $42,345 
Amortization of Intangible Assets and Impairment of Long-Lived Assets
Education$2,974 $4,416 
Television broadcasting1,350 1,362 
Manufacturing3,120 4,862 
Healthcare636 954 
Automotive  
Other businesses2,671 3,095 
Corporate office  
$10,751 $14,689 
Income (Loss) from Operations
Education$30,587 $23,040 
Television broadcasting29,633 28,583 
Manufacturing3,069 7,328 
Healthcare6,091 2,936 
Automotive9,652 10,843 
Other businesses(28,954)(31,001)
Corporate office(14,636)(14,073)
  $35,442 $27,656 
Equity in Earnings of Affiliates, Net
2,331 4,661 
Interest Expense, Net(17,150)(13,090)
Non-Operating Pension and Postretirement Benefit Income, Net
42,417 31,845 
Gain on Marketable Equity Securities, Net
104,152 18,022 
Other Income, Net
1,647 3,083 
Income Before Income Taxes
$168,839 $72,177 
20


  Three Months Ended 
 March 31
(in thousands)20242023
Depreciation of Property, Plant and Equipment
Education$9,305 $8,968 
Television broadcasting2,868 3,036 
Manufacturing2,715 2,282 
Healthcare1,594 1,104 
Automotive1,713 1,113 
Other businesses4,183 3,369 
Corporate office149 153 
  $22,527 $20,025 
Pension Service Cost  
Education$4,110 $2,198 
Television broadcasting1,639 860 
Manufacturing627 275 
Healthcare4,758 4,357 
Automotive15 5 
Other businesses1,940 572 
Corporate office945 976 
  $14,034 $9,243 
Asset information for the Company’s business segments is as follows:
  As of
(in thousands)March 31, 2024December 31, 2023
Identifiable Assets    
Education$1,939,781 $2,021,471 
Television broadcasting419,819 419,557 
Manufacturing436,797 431,712 
Healthcare267,707 265,150 
Automotive623,376 597,267 
Other businesses364,656 368,542 
Corporate office92,331 93,760 
  $4,144,467 $4,197,459 
Investments in Marketable Equity Securities794,305 690,153 
Investments in Affiliates186,674 186,480 
Prepaid Pension Cost2,129,682 2,113,638 
Total Assets$7,255,128 $7,187,730 
21


The Company’s education division comprises the following operating segments:
  Three Months Ended 
 March 31
  
(in thousands)20242023
Operating Revenues  
Kaplan international$269,798 $227,076 
Higher education80,122 78,341 
Supplemental education72,122 73,587 
Kaplan corporate and other2,588 2,372 
Intersegment elimination(2,032)(3,335)
  $422,598 $378,041 
Income (Loss) from Operations before Amortization of Intangible Assets and Impairment of Long-Lived Assets
Kaplan international$31,312 $21,301 
Higher education5,519 7,083 
Supplemental education4,580 3,751 
Kaplan corporate and other(7,585)(4,838)
Intersegment elimination(265)159 
$33,561 $27,456 
Amortization of Intangible Assets$2,974 $3,939 
Impairment of Long-Lived Assets$ $477 
Income (Loss) from Operations    
Kaplan international$31,312 $21,301 
Higher education5,519 7,083 
Supplemental education4,580 3,751 
Kaplan corporate and other(10,559)(9,254)
Intersegment elimination(265)159 
  $30,587 $23,040 
Depreciation of Property, Plant and Equipment
    
Kaplan international$7,356 $6,330 
Higher education903 1,102 
Supplemental education1,019 1,509 
Kaplan corporate and other27 27 
  $9,305 $8,968 
Pension Service Cost    
Kaplan international$163 $80 
Higher education1,781 922 
Supplemental education1,818 1,024 
Kaplan corporate and other348 172 
  $4,110 $2,198 
Asset information for the Company’s education division is as follows:
  As of
(in thousands)March 31, 2024December 31, 2023
Identifiable Assets    
Kaplan international$1,453,727 $1,537,989 
Higher education200,115 187,972 
Supplemental education237,263 249,519 
Kaplan corporate and other48,676 45,991 
  $1,939,781 $2,021,471 

22


Item 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition.
This analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto.
Results of Operations
The Company reported net income attributable to common shares of $124.4 million ($27.72 per share) for the first quarter of 2024, compared to $52.3 million ($10.88 per share) for the first quarter of 2023.
Items included in the Company’s net income for the first quarter of 2024:
$0.4 million in expenses related to a non-operating Separation Incentive Program (SIP) at other businesses (after tax-impact of $0.3 million, or $0.07 per share);
$104.2 million in net gains on marketable equity securities (after-tax impact of $77.5 million, or $17.27 per share);
$1.5 million in net losses of affiliates whose operations are not managed by the Company (after-tax impact of $1.1 million, or $0.25 per share);
non-operating loss of $0.4 million from the impairment of a cost method investment (after-tax impact of $0.3 million, or $0.07 per share); and
$1.9 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $1.8 million, or $0.40 per share).
Items included in the Company’s net income for the first quarter of 2023:
$4.1 million in expenses related to non-operating SIPs at other businesses (after-tax impact of $3.1 million, or $0.64 per share);
$18.0 million in net gains on marketable equity securities (after-tax impact of $13.3 million, or $2.76 per share);
$1.8 million in net earnings of affiliates whose operations are not managed by the Company (after-tax impact of $1.3 million, or $0.28 per share);
non-operating gain of $2.6 million from the write-up and sale of a cost method investment (after-tax impact of $2.0 million, or $0.41 per share); and
$1.5 million in interest expense to adjust the fair value of the mandatorily redeemable noncontrolling interest (after-tax impact of $1.4 million, or $0.29 per share).
Revenue for the first quarter of 2024 was $1,152.7 million, up 12% from $1,031.5 million in the first quarter of 2023. Revenues increased at education, healthcare and automotive, partially offset by declines at manufacturing and other businesses. The Company reported operating income of $35.4 million for the first quarter of 2024, compared to $27.7 million for the first quarter of 2023. The improvement in operating results is due to increases at education, television broadcasting and healthcare, and reduced losses at other businesses, partially offset by declines at manufacturing and automotive.
Division Results
Education
Education division revenue totaled $422.6 million for the first quarter of 2024, up 12% from $378.0 million for the same period of 2023. Kaplan reported operating income of $30.6 million for the first quarter of 2024, compared to $23.0 million for the first quarter of 2023.
In the second quarter of 2023, Kaplan modified its segment reporting for Kaplan India, a shared services center that supports Higher Education (previously included in Kaplan corporate and other); prior periods have been reclassified to conform with the current presentation.
23


A summary of Kaplan’s operating results is as follows:
Three Months Ended
  March 31  
(in thousands)20242023% Change
Revenue      
Kaplan international$269,798 $227,076 19 
Higher education80,122 78,341 
Supplemental education72,122 73,587 (2)
Kaplan corporate and other2,588 2,372 
Intersegment elimination(2,032)(3,335)— 
  $422,598 $378,041 12 
Operating Income (Loss)      
Kaplan international$31,312 $21,301 47 
Higher education5,519 7,083 (22)
Supplemental education4,580 3,751 22 
Kaplan corporate and other(7,585)(4,838)(57)
Amortization of intangible assets(2,974)(3,939)24 
Impairment of long-lived assets
 (477)— 
Intersegment elimination(265)159 — 
  $30,587 $23,040 33 
Kaplan International includes postsecondary education, professional training and language training businesses largely outside the United States (U.S.). Kaplan International revenue increased 19% for the first quarter of 2024 (16% on a constant currency basis). The increase is due largely to growth at Pathways, Australia, UK Professional and Singapore. Kaplan International reported operating income of $31.3 million in the first quarter of 2024, compared to $21.3 million in the first quarter of 2023. The improved results are due largely to improved results at Pathways, Australia, UK Professional and Singapore, partially offset by a decline at Languages.
Higher Education includes the results of Kaplan as a service provider to higher education institutions. Higher Education revenue increased 2% for the first quarter of 2024 due to revenue growth across most of the institutions served. Enrollments at Purdue Global, the largest institutional client, increased slightly compared to the first quarter of 2023. For the first quarter of 2024 and 2023, Kaplan recorded a portion of the fee from Purdue Global. The Company will continue to assess the fee it records from Purdue Global on a quarterly basis to make a determination as to whether to record all or part of the fee in the future and whether to adjust fee amounts recognized in earlier periods. Purdue Global’s available cash position under the TOSA at the end of its fiscal year (June 30) is an important determinant in the amount of fee recorded by Kaplan. Consequently, the timing of cash inflows and outflows close to Purdue Global’s fiscal year-end can significantly impact the amount of fee Kaplan records from Purdue Global. Higher Education operating results declined in the first quarter of 2024 due to a lower Purdue Global fee recorded compared to the first quarter of 2023 and an increase in higher education development costs.
Supplemental Education includes Kaplan’s standardized test preparation programs and domestic professional and other continuing education businesses. Supplemental Education revenue declined 2% for the first quarter of 2024, driven mostly by softness in Medical Licensure test preparation and publishing activities and Real Estate, offset in part by growth in Insurance, CFA, Architecture and Engineering and MCAT test preparation. Overall, demand for graduate and pre-college test preparation programs has declined due to the strength of U.S. employment markets and the decline in test-takers, while demand for professional programs remained stable. Operating results improved in the first quarter of 2024 due to cost reductions from lower headcount, partially offset by lower revenues.
Kaplan corporate and other represents unallocated expenses of Kaplan, Inc.’s corporate office, other minor businesses and certain shared activities. Kaplan corporate and other expenses increased in the first quarter of 2024, largely due to increased employee benefit and incentive compensation costs.
Television Broadcasting
A summary of television broadcasting’s operating results is as follows:
Three Months Ended
  March 31  
(in thousands)20242023% Change
Revenue$113,058 $112,877 
Operating Income29,633 28,583 
Graham Media Group, Inc. owns seven television stations located in Houston, TX; Detroit, MI; Orlando, FL; San Antonio, TX; Jacksonville, FL; and Roanoke, VA, as well as SocialNewsDesk, a provider of social media
24


management tools designed to connect newsrooms with their users. Revenue at the television broadcasting division increased slightly to $113.1 million in the first quarter of 2024, from $112.9 million in the same period of 2023. The revenue increase is due to a $1.5 million increase in political advertising revenue and a modest increase in digital advertising revenues, partially offset by a decline in other advertising revenue. Retransmission revenues were flat in the first quarter of 2024. Operating income for the first quarter of 2024 increased 4% to $29.6 million, from $28.6 million in the same period of 2023, due to slightly higher revenues and lower overall costs, partially offset by increased pension expense.
While per subscriber rates from cable, satellite and OTT providers have grown, overall cable and satellite subscribers are down due to cord cutting, resulting in retransmission revenue net of network fees in 2024 expected to decline compared with 2023, and this trend is expected to continue.
Manufacturing
A summary of manufacturing’s operating results is as follows:
Three Months Ended
  March 31  
(in thousands)20242023% Change
Revenue$101,903 $114,584 (11)
Operating Income
3,069 7,328 (58)
Manufacturing includes four businesses: Hoover, a supplier of pressure impregnated kiln-dried lumber and plywood products for fire retardant and preservative applications; Dekko, a manufacturer of electrical workspace solutions, architectural lighting and electrical components and assemblies; Joyce/Dayton, a manufacturer of screw jacks and other linear motion systems; and Forney, a global supplier of products and systems that control and monitor combustion processes in electric utility and industrial applications.
Manufacturing revenues decreased 11% in the first quarter of 2024 due to lower revenues at Hoover, Dekko and Joyce, partially offset by increased revenues at Forney. The revenue decline at Hoover is due largely to a decrease in volumes and overall product demand, particularly for multi-family housing. Revenues declined at Dekko due to lower product demand. Overall, Hoover results included wood gains on inventory sales in the first quarter of 2024 and 2023, with gains in the first quarter of 2024 lower than the prior year. Manufacturing operating results were down in the first quarter of 2024 due largely to a significant decline at Hoover, along with declines at Joyce and Forney.
Healthcare
A summary of healthcare’s operating results is as follows:
Three Months Ended
  March 31  
(in thousands)20242023% Change
Revenue$128,201 $102,059 26 
Operating Income6,091 2,936 — 
Graham Healthcare Group (GHG) provides home health and hospice services in seven states. GHG also provides other healthcare services, including nursing care and prescription services for patients receiving in-home infusion treatments through its 86.7% interest in CSI Pharmacy Holding Company, LLC (CSI). Healthcare revenues increased 26% for the first quarter of 2024 due largely to significant growth at CSI, along with growth in home health and hospice services and the other healthcare businesses. The increase in GHG operating results in the first quarter of 2024 is due largely to improved results at CSI and in home health.
The Company also holds interests in four home health and hospice joint ventures managed by GHG, whose results are included in equity in earnings of affiliates in the Company’s Condensed Consolidated Statements of Operations. The Company recorded equity in earnings of $3.4 million and $2.7 million for the first quarter of 2024 and 2023, respectively, from these joint ventures.
25


Automotive
A summary of automotive’s operating results is as follows:
Three Months Ended
  March 31  
(in thousands)20242023% Change
Revenue$303,840 $232,561 31 
Operating Income9,652 10,843 (11)
Automotive includes eight automotive dealerships in the Washington, D.C. metropolitan area and Richmond, VA: Ourisman Lexus of Rockville, Ourisman Honda of Tysons Corner, Ourisman Jeep Bethesda, Ourisman Ford of Manassas, Toyota of Woodbridge, Ourisman Chrysler-Dodge-Jeep-Ram (CDJR) of Woodbridge and Ourisman Toyota of Richmond, which was acquired on September 27, 2023 from McGeorge Toyota. The automotive group was awarded a Kia Open Point dealership in Bethesda, MD, which commenced operations at the end of December 2023. Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships, and his team of industry professionals operate and manage the dealerships; the Company holds a 90% stake.
Revenues for the first quarter of 2024 increased 31% due largely to the Toyota of Richmond acquisition and the addition of the Kia dealership, as well as sales growth for new and used vehicles and for services and parts. Operating results for the first quarter of 2024 declined due largely to lower overall gross margins on new and used vehicles, partially offset by earnings from the Toyota of Richmond acquisition and higher overall gross margins on services and parts.
Other Businesses
A summary of revenue by category for other businesses:
Three Months Ended
March 31%
(in thousands)20242023Change
Operating Revenues
Retail (1)
$26,036 $32,397 (20)
Media (2)
23,096 25,404 (9)
Specialty (3)
34,166 34,207 
$83,298 $92,008 (9)
____________
(1)
Includes Society6 and Saatchi Art (formerly Leaf Marketplace) and Framebridge
(2)
Includes World of Good Brands (formerly Leaf Media), Code3, Slate, Foreign Policy, Pinna and City Cast
(3)
Includes Clyde’s Restaurant Group, Decile and Supporting Cast
Overall, revenue from other businesses declined 9% in the first quarter of 2024. Retail revenue declined largely due to lower revenue at Society6, partially offset by revenue growth at Saatchi Art and Framebridge. Media revenue declined due to lower revenue at World of Good Brands (WGB) and Code3, partially offset by revenue growth at Slate, Foreign Policy and City Cast. Specialty revenue was flat due to lower revenue at Clyde’s Restaurant Group (CRG), partially offset by revenue growth at Decile and Supporting Cast. Excluding the former Leaf businesses, revenue from other businesses grew in the first quarter of 2024.
Overall, operating results at other businesses improved in the first quarter of 2024 due primarily to improved results at Slate.
Leaf Group
On June 14, 2021, the Company acquired Leaf Group Ltd. (Leaf), a consumer internet company headquartered in Santa Monica, CA, that builds enduring, creator-driven brands that reach passionate audiences in large and growing lifestyle categories, including fitness and wellness (Well+Good and Livestrong.com), and home, art and design (Saatchi Art, Society6 and Hunker).
26


In the second quarter of 2023, the Company restructured Leaf into three stand-alone businesses: Society6 (formerly included in Leaf Marketplace), Saatchi Art (formerly included in Leaf Marketplace) and WGB (formerly Leaf Media). The transition process for this restructuring involves various cost reduction initiatives, including elimination of shared services costs and functions; transitioning financial and human resources systems; and rationalizing physical facilities and data centers. In the first and second quarters of 2023, Leaf implemented a SIP to reduce the number of employees, which was funded by the assets of the Company’s pension plan; $2.9 million and $3.9 million in related non-operating pension expense was recorded in the first and second quarters of 2023, respectively. Each of Society6, Saatchi Art and WGB is continuing with the transition and cost reduction process, which is expected to be largely completed by the end of the second quarter of 2024.
Revenues at Society6 and WGB declined substantially in the first quarter of 2024. Revenue declines at Society6 are due to declines in traffic, largely driven by a significant decrease in advertising spend, as well as softer demand in the home decor category. Revenue declines at WGB are due to reduced traffic and the soft digital advertising market for both direct and programmatic categories. Revenues at Saatchi Art grew in the first quarter of 2024. Overall, the Leaf businesses reported significant operating losses in each of the first quarters of 2024 and 2023, with a small decline in operating losses in the first quarter of 2024.
Clyde’s Restaurant Group
CRG owns and operates 12 restaurants and entertainment venues in the Washington, D.C. metropolitan area, including Old Ebbitt Grill and The Hamilton. Both revenues and operating results declined in the first quarter of 2024, due to overall lower guest traffic in the first two months of 2024. CRG reported an operating profit in each of the first quarters of 2024 and 2023.
CRG plans to open new restaurants in Baltimore, MD; Washington, D.C.; and Reston, VA in mid 2024, late 2024 and late 2025, respectively.
Framebridge
Framebridge is a custom framing service company, headquartered in Washington, D.C., with 22 retail locations in the Washington, D.C., New York City, Atlanta, GA, Philadelphia, PA, Boston, MA and Chicago, IL areas and two manufacturing facilities in Kentucky and New Jersey. Framebridge plans to open additional stores in 2024, including an expansion into Texas, and continues to actively explore other opportunities for further store expansion.
Revenues increased modestly in the first quarter of 2024 due to an increase in retail revenue from same-store sales growth and operating additional retail stores compared to the same period in 2023. Framebridge is an investment stage business and reported significant operating losses in the first quarters of 2024 and 2023.
In the first quarter of 2024, Framebridge implemented a SIP, which will be funded by the assets of the Company’s pension plan; $0.4 million in related non-operating pension expense was recorded in the first quarter of 2024.
Other
Other businesses also include Code3, a performance marketing agency focused on driving performance for brands though three core elements of digital success: media, creative and commerce; Slate and Foreign Policy, which publish online and print magazines and websites; and three investment stage businesses, Decile, City Cast and Supporting Cast. Slate, Foreign Policy, Decile, City Cast and Supporting Cast reported revenue growth in the first quarter of 2024, while Code3 reported a revenue decline. Losses from City Cast, Decile, Code3, Foreign Policy and Supporting Cast in the first quarter of 2024 adversely affected operating results, while Slate reported an operating profit during this period.
Other businesses also included Pinna, which was sold in June 2023 when the Company entered into a merger agreement with Realm of Possibility, Inc. (Realm), a provider of audio entertainment services, to merge Pinna with Realm in return for a noncontrolling financial interest in the merged entity. The Company’s investment in Realm is reported as an equity method investment.
In the first quarter of 2023, Code3 implemented a SIP to reduce the number of employees, which was funded by the assets of the Company’s pension plan; $1.2 million in related non-operating pension expense was recorded in the first quarter of 2023.
Corporate Office
Corporate office includes the expenses of the Company’s corporate office and certain continuing obligations related to prior business dispositions.

27


Employee Benefit Plan Changes
Effective January 1, 2024, the Company’s defined benefit pension plan was amended to provide many of the current employees who are current plan participants with an increased pension benefit, and to provide certain current employees from several business units with a new pension benefit offering. The increased and new pension benefits will be funded by the assets of the Company’s pension plan. As a result of these changes, the Company’s matching contribution to certain of its 401(k) Savings Plans was eliminated.
Equity in Earnings of Affiliates
At March 31, 2024, the Company held an approximate 18% interest in Intersection Holdings, LLC (Intersection), a company that provides digital marketing and advertising services and products for cities, transit systems, airports, and other public and private spaces; a 49.9% interest on a fully diluted basis in N2K Networks, a cybersecurity workforce intelligence company; and a 42.2% interest on a fully diluted basis in Realm. The Company also holds interests in several other affiliates, including a number of home health and hospice joint ventures managed by GHG and two joint ventures managed by Kaplan. Overall, the Company recorded equity in earnings of affiliates of $2.3 million for the first quarter of 2024, compared to $4.7 million for the first quarter of 2023. These amounts include $1.5 million in net losses for the first quarter of 2024 and $1.8 million in net earnings for the first quarter of 2023, from affiliates whose operations are not managed by the Company.
Net Interest Expense and Related Balances
The Company incurred net interest expense of $17.2 million for the first quarter of 2024, compared to $13.1 million for the first quarter of 2023. The Company recorded interest expense of $1.9 million and $1.5 million in the first quarter of 2024 and 2023, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest at GHG. Excluding these adjustments, the increase in net interest expense relates primarily to higher debt balances at the automotive dealerships, higher interest rates on the Company’s variable debt, and increased floor plan interest expense.
At March 31, 2024, the Company had $815.6 million in borrowings outstanding at an average interest rate of 6.4%, and cash, marketable equity securities and other investments of $981.9 million. At March 31, 2024, the Company had $108.1 million outstanding on its $300 million revolving credit facility.
Non-operating Pension and Postretirement Benefit Income, net
The Company recorded net non-operating pension and postretirement benefit income of $42.4 million for the first quarter of 2024, compared to $31.8 million for the first quarter of 2023.
In the first quarter of 2024 and 2023, the Company recorded $0.4 million and $4.1 million, respectively, in expenses related to non-operating SIPs at other businesses.
Gain on Marketable Equity Securities, net
Overall, the Company recognized $104.2 million and $18.0 million in net gains on marketable equity securities in the first quarter of 2024 and 2023, respectively.
Other Non-Operating Income
The Company recorded total other non-operating income, net, of $1.6 million for the first quarter of 2024, compared to $3.1 million for the first quarter of 2023. The 2024 amounts included $0.9 million in gains related to the sale of businesses and contingent consideration; $0.6 million in foreign currency gains, and other items; partially offset by a $0.4 million impairment on a cost method investment. The 2023 amounts included a $1.8 million fair value increase on a cost method investment; $1.0 million in gains related to the sale of businesses and contingent consideration; a $0.8 million gain on sale of a cost method investment, and other items; partially offset by $1.5 million in foreign currency losses.
Provision for Income Taxes
The Company’s effective tax rate for the first quarter of 2024 and 2023 was 25.8% and 26.6%, respectively.
Earnings Per Share
The calculation of diluted earnings per share for the first quarter of 2024 was based on 4,456,825 weighted average shares outstanding, compared to 4,775,586 for the first quarter of 2023. At March 31, 2024, there were 4,450,593 shares outstanding. On May 4, 2023, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock; the Company has remaining authorization for 207,797 shares as of March 31, 2024.
28


Financial Condition: Liquidity and Capital Resources
The Company considers the following when assessing its liquidity and capital resources:
 As of
(In thousands)March 31, 2024December 31, 2023
Cash and cash equivalents$130,860 $169,897 
Restricted cash48,123 31,994 
Investments in marketable equity securities and other investments802,943 697,028 
Total debt815,552 811,833 
Cash generated by operations is the Company’s primary source of liquidity. The Company maintains investments in a portfolio of marketable equity securities, which is considered when assessing the Company’s sources of liquidity. An additional source of liquidity includes the undrawn portion of the Company’s $300 million revolving credit facility, amounting to $191.9 million at March 31, 2024 and the undrawn $50.0 million delayed draw term loan at the automotive subsidiary.
During the first three months of 2024, the Company’s cash and cash equivalents decreased by $39.0 million, due to share repurchases, capital expenditures, and dividend payments, which was offset by net proceeds from the vehicle floor plan payable and net borrowings. In the first three months of 2024, the Company’s borrowings increased by $3.7 million, primarily due to additional borrowings under the revolving credit facility, partially offset by repayments under the revolving credit facility, term loan and commercial notes at the automotive subsidiary.
As of March 31, 2024 and December 31, 2023, the Company had money market investments of $7.5 million and $5.6 million, that are included in cash and cash equivalents. At March 31, 2024, the Company held approximately $97 million in cash and cash equivalents in businesses domiciled outside the U.S., of which approximately $8 million is not available for immediate use in operations or for distribution. Additionally, Kaplan’s business operations outside the U.S. retain cash balances to support ongoing working capital requirements, capital expenditures, and regulatory requirements. As a result, the Company considers a significant portion of the cash and cash equivalents balance held outside the U.S. as not readily available for use in U.S. operations.
At March 31, 2024, the fair value of the Company’s investments in marketable equity securities was $794.3 million, which includes investments in the common stock of four publicly traded companies. There were no purchases or sales of marketable equity securities during the first three months of 2024. At March 31, 2024, the unrealized gain related to the Company’s investments totaled $568.3 million.
In April 2023, the Company entered into a term note agreement to loan Intersection $30.0 million at an interest rate of 9% per annum. The principal and interest on the note are payable in monthly installments over 5 years with the final payment due by May 2028. The outstanding balance on this loan was $28.3 million as of March 31, 2024.
The Company had working capital of $709.1 million and $619.6 million at March 31, 2024 and December 31, 2023, respectively. The Company maintains working capital levels consistent with its underlying business requirements and consistently generates cash from operations in excess of required interest or principal payments.
At March 31, 2024 and December 31, 2023, the Company had borrowings outstanding of $815.6 million and $811.8 million, respectively. The Company’s borrowings at March 31, 2024 were mostly from $400.0 million of 5.75% unsecured notes due June 1, 2026, $108.1 million in outstanding borrowings under the Company’s revolving credit facility, a term loan of $145.6 million, and real estate and capital term loans of $135.1 million at the automotive subsidiary. The Company’s borrowings at December 31, 2023 were mostly from $400.0 million of 5.75% unsecured notes due June 1, 2026, $97.9 million in outstanding borrowings under the Company’s revolving credit facility, a term loan of $147.5 million, and real estate and capital term loans of $137.6 million at the automotive subsidiary. The interest on the $400.0 million of 5.75% unsecured notes is payable semiannually on June 1 and December 1.
During the three months ended March 31, 2024 and 2023, the Company had average borrowings outstanding of approximately $810.7 million and $735.0 million, respectively, at average annual interest rates of approximately 6.4% and 5.8%, respectively. During the three months ended March 31, 2024 and 2023, the Company incurred net interest expense of $17.2 million and $13.1 million, respectively. Included in the interest expense for the three months ended March 31, 2024 and 2023 is $1.9 million and $1.5 million, respectively, to adjust the fair value of the mandatorily redeemable noncontrolling interest (see Note 7).
On April 2, 2024, Standard & Poor’s affirmed the Company’s credit rating and maintained the outlook as Stable. On August 17, 2023, Moody’s affirmed the Company’s credit rating and maintained the outlook as Stable.
29


The Company’s current credit ratings are as follows:
Moody’sStandard & Poor’s
Long-termBa1BB
OutlookStableStable
The Company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility. As of March 31, 2024, the Company had $108.1 million outstanding under the $300 million revolving credit facility. In management’s opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.
In summary, the Company’s cash flows for each period were as follows:
 Three Months Ended 
 March 31
(In thousands)20242023
Net cash provided by operating activities$1,067 $22,811 
Net cash used in investing activities(20,962)(1,954)
Net cash provided by (used in) financing activities1,526 (57,802)
Effect of currency exchange rate change(4,539)1,235 
Net decrease in cash and cash equivalents and restricted cash$(22,908)$(35,710)
Operating Activities. Cash provided by operating activities is net income adjusted for certain non-cash items and changes in assets and liabilities. The Company’s net cash flow provided by operating activities were as follows:
 Three Months Ended 
 March 31
(In thousands)20242023
Net Income$125,339 $52,977 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation, amortization and long-lived asset impairments33,278 34,714 
Amortization of lease right-of-use asset16,866 16,492 
Net pension benefit and special separation benefit expense
(29,056)(23,162)
Other non-cash activities(89,016)(24,778)
Change in operating assets and liabilities(56,344)(33,432)
Net Cash Provided by Operating Activities$1,067 $22,811 
Net cash provided by operating activities consists primarily of cash receipts from customers, less disbursements for costs, benefits, income taxes, interest and other expenses.
For the first three months of 2024 compared to the first three months of 2023, the decrease in net cash provided by operating activities is primarily driven by a decrease in customer collections and higher purchases of inventories in 2024 compared to 2023.
Investing Activities. The Company’s net cash flow used in investing activities were as follows:
 Three Months Ended 
 March 31
(In thousands)20242023
Purchases of property, plant and equipment$(21,258)$(22,554)
Investments in equity affiliates, cost method and other investments(526)(4,735)
Net proceeds from sales of marketable equity securities 22,866 
Other822 2,469 
Net Cash Used in Investing Activities$(20,962)$(1,954)
Capital Expenditures. The amounts reflected in the Company’s Condensed Consolidated Statements of Cash Flows are based on cash payments made during the relevant periods, whereas the Company’s capital expenditures for the first three months of 2024 of $21.5 million include assets acquired during the period. The Company estimates that its capital expenditures will be in the range of $95 million to $105 million in 2024.
30


Net proceeds from sale of marketable equity securities. There were no purchases or sales of marketable equity securities during the first three months of 2024. During the first three months of 2023, the Company sold marketable equity securities that generated proceeds of $29.0 million and purchased $4.6 million of marketable equity securities.
Financing Activities. The Company’s net cash flow provided by (used in) financing activities were as follows:
 Three Months Ended 
 March 31
(In thousands)20242023
Net borrowings (payments) under revolving credit facility$9,245 $(33,000)
Repayments of borrowings(4,902)(3,999)
Net proceeds from vehicle floor plan payable26,803 7,196 
Common shares repurchased(20,028)(23,439)
Dividends paid(7,678)(7,910)
Other(1,914)3,350 
Net Cash Provided by (Used in) Financing Activities$1,526 $(57,802)
Borrowings and Vehicle Floor Plan Payable. In the first three months of 2024, the Company made additional borrowings on the $300 million revolving credit facility. In the first three months of 2023, the Company made repayments on the $300 million revolving credit facility. In the first three months of 2024 and 2023, the Company used vehicle floor plan financing to fund the purchase of new, used and service loaner vehicles at its automotive subsidiary. The proceeds from the vehicle floor plan payable fluctuates with changes in the amount of vehicle inventory held by the automotive dealerships.
Common Stock Repurchases. During the first three months of 2024, the Company purchased a total of 28,606 shares of its Class B common stock at a cost of approximately $20.2 million, including commissions and accrued excise tax of $0.2 million. On May 4, 2023, the Board of Directors authorized the Company to acquire up to 500,000 shares of its Class B common stock. The Company did not announce a ceiling price or time limit for the purchases. At March 31, 2024, the Company had remaining authorization from the Board of Directors to purchase up to 207,797 shares of Class B common stock.
Dividends. The quarterly dividend rate per share was $1.72 and $1.65 for the first three months of 2024 and 2023, respectively. The Company expects to pay a dividend of $6.88 per share in 2024.
There were no other significant changes to the Company’s contractual obligations or other commercial commitments from those disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.
Forward-Looking Statements
All public statements made by the Company and its representatives that are not statements of historical fact, including certain statements in this report, in the Company’s Annual Report on Form 10-K and in the Company’s 2023 Annual Report to Stockholders, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations, forecasts, and assumptions by the Company’s management and involve a number of risks, uncertainties, and other factors that could cause actual results to differ from those stated, including, without limitation, comments about expectations related to acquisitions or dispositions or related business activities, the Company’s business strategies and objectives, the prospects for growth in the Company’s various business operations, the Company’s future financial performance, and the risks and uncertainties described in Item 1A of the Company’s Annual Report on Form 10-K. Accordingly, undue reliance should not be placed on any forward-looking statement made by or on behalf of the Company. The Company assumes no obligation to update any forward-looking statement after the date on which such statement is made, even if new information subsequently becomes available.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The Company is exposed to market risk in the normal course of its business due primarily to its ownership of marketable equity securities, which are subject to equity price risk; to its borrowing and cash-management activities, which are subject to interest rate risk; and to its foreign business operations, which are subject to foreign exchange rate risk. The Company’s market risk disclosures set forth in its 2023 Annual Report filed on Form 10-K have not otherwise changed significantly.
31


Item 4. Controls and Procedures.
(a) Evaluation of Disclosure Controls and Procedures
An evaluation was performed by the Company’s management, with the participation of the Company’s Chief Executive Officer (principal executive officer) and the Company’s Chief Financial Officer (principal financial officer), of the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), as of March 31, 2024. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures, as designed and implemented, are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, in a manner that allows timely decisions regarding required disclosure.
(b) Changes in Internal Control Over Financial Reporting
There has been no change in the Company’s internal control over financial reporting during the quarter ended March 31, 2024 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
32


PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
During the quarter ended March 31, 2024, the Company purchased shares of its Class B Common Stock as set forth in the following table:
PeriodTotal Number of Shares Purchased
Average Price Paid per Share(1)
Total Number of Shares Purchased as Part of Publicly Announced Plan(2)
Maximum Number of Shares that May Yet Be Purchased Under the Plan(2)
January 1 - 3115,576 $693.31 15,576 220,827 
February 1 - 292,970 704.20 2,970 217,857 
March 1 - 3110,060 729.24 10,060 207,797 
28,606 $707.07 28,606 
(1) Average price paid per share includes costs associated with repurchases, including commissions and excise taxes.
(2) On May 4, 2023, the Company’s Board of Directors authorized the Company to purchase, on the open market or otherwise, up to 500,000 shares of its Class B Common Stock. This authorization includes shares that remained under the previous authorization. There is no expiration date for this authorization. All purchases made during the quarter ended March 31, 2024 were open market transactions and some of these shares were purchased under a 10b5-1 plan.
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the quarter ended March 31, 2024, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K.
33


Item 6. Exhibits.
Exhibit Number 
Description 
3.1
3.2
3.3
4.1
4.2
4.3
4.4
31.1
31.2
32
101.INS
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101
*     Furnished herewith.
34


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  GRAHAM HOLDINGS COMPANY
  (Registrant)
   
Date: May 1, 2024 /s/ Timothy J. O’Shaughnessy
  
Timothy J. O’Shaughnessy,
President & Chief Executive Officer
(Principal Executive Officer)
   
Date: May 1, 2024 /s/ Wallace R. Cooney
  Wallace R. Cooney,
Chief Financial Officer
(Principal Financial Officer)
35